Skip to main content

Client News

Medigene AG Reports Second Quarter and Six Months 2023 Financial Results and Provides Corporate Update

17th August 2023

Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update

15th August 2023

InflaRx Reports Second Quarter 2023 Financial Results & Operating Update

10th August 2023

Newron announces H1 2023 results and provides R&D update

4th August 2023

Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom

1st August 2023

Destiny Pharma: Publication of new data demonstrates significantly superior efficacy of XF-73 compared to a leading topical antibiotic against MRSA in skin infection models

31st July 2023

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

20th July 2023

Destiny Pharma: Board changes including appointment of new CEO

19th July 2023

leon-nanodrugs appoints Dr. Hans Frickel as Chief Executive Officer

18th July 2023

Mainz Biomed Announces Collaboration with Fugene Genetics in Israel

18th July 2023